GMYPX
Price
$16.55
Change
-$0.45 (-2.65%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GMYPX vs RMFCX

Header iconGMYPX vs RMFCX Comparison
Open Charts GMYPX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value P
Price$16.55
Change-$0.45 (-2.65%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GMYPX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMYPX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMYPX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GMYPX (446M). RMFCX pays higher dividends than GMYPX: RMFCX (1.69) vs GMYPX (1.19). GMYPX was incepted earlier than RMFCX: GMYPX (7 years) vs RMFCX (23 years). GMYPX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). GMYPX has a lower initial minimum investment than RMFCX: GMYPX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. GMYPX (10.93). RMFCX return over 5 years is better than : 40.39 vs. GMYPX (16.49).
GMYPXRMFCXGMYPX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD9.32611.42382%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets446M98.7B0%
Annual Yield % from dividends1.191.6970%
Returns for 1 year10.9312.6387%
Returns for 3 years6.3614.1645%
Returns for 5 years16.4940.3941%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc